###begin article-title 0
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance
###end article-title 0
###begin p 1
Conceived and designed the experiments: PJ JMC. Performed the experiments: PJ RAR JMC. Analyzed the data: PJ JMC. Contributed reagents/materials/analysis tools: PJ RAR VP JMC. Wrote the paper: PJ RAR VP JMC.
###end p 1
###begin p 2
###xml 774 783 774 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 1364 1372 1364 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 246 251 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 281 286 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 581 586 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 741 746 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 968 973 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1165 1170 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1334 1339 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1398 1403 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The role of APOBEC3 (A3) protein family members in inhibiting retrovirus infection and mobile element retrotransposition is well established. However, the evolutionary effects these restriction factors may have had on active retroviruses such as HIV-1 are less well understood. An HIV-1 variant that has been highly G-to-A mutated is unlikely to be transmitted due to accumulation of deleterious mutations. However, G-to-A mutated hA3G target sequences within which the mutations are the least deleterious are more likely to survive selection pressure. Thus, among hA3G targets in HIV-1, the ratio of nonsynonymous to synonymous changes will increase with virus generations, leaving a footprint of past activity. To study such footprints in HIV-1 evolution, we developed an in silico model based on calculated hA3G target probabilities derived from G-to-A mutation sequence contexts in the literature. We simulated G-to-A changes iteratively in independent sequential HIV-1 infections until a stop codon was introduced into any gene. In addition to our simulation results, we observed higher ratios of nonsynonymous to synonymous mutation at hA3G targets in extant HIV-1 genomes than in their putative ancestral genomes, compared to random controls, implying that moderate levels of A3G-mediated G-to-A mutation have been a factor in HIV-1 evolution. Results from in vitro passaging experiments of HIV-1 modified to be highly susceptible to hA3G mutagenesis verified our simulation accuracy. We also used our simulation to examine the possible role of A3G-induced mutations in the origin of drug resistance. We found that hA3G activity could have been responsible for only a small increase in mutations at known drug resistance sites and propose that concerns for increased resistance to other antiviral drugs should not prevent Vif from being considered a suitable target for development of new drugs.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 139 144 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 237 242 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 476 481 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 557 562 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 808 813 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The search for new drugs to battle HIV-1 infections is a continuing struggle. APOBEC3G proteins have been shown to deaminate C-residues in HIV-1 minus strand DNA during its synthesis, resulting in G-to-A mutations in the RNA genome. The HIV-1 Vif protein has evolved to counteract APOBEC3G and thereby escape these frequently deleterious mutations, making Vif an attractive target for new drugs. However, a partial block of Vif could result in an increased although low-level HIV-1 G-to-A mutation rate. Here we investigated APOBEC3G mutation footprints in HIV-1 evolution and the potential risk for known drug resistance from sublethal G-to-A mutations. Using computer simulations, the accuracies of which were verified by infection experiments, we detected evolutionary APOBEC3G mutation footprints in the HIV-1 genome. We predict that the risk that APOBEC3G-induced G-to-A mutations will cause drug resistance is very low. We therefore propose that concerns for increased resistance to other antiviral drugs should not prevent Vif from being considered a suitable target for development of new drugs.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Esnault1">[1]</xref>
###xml 163 166 163 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Okeoma1">[3]</xref>
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Telesnitsky1">[4]</xref>
###xml 450 453 450 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Bishop1">[5]</xref>
###xml 454 457 454 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Zhang1">[8]</xref>
###xml 656 659 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Yu1">[9]</xref>
###xml 834 838 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene1">[10]</xref>
###xml 1125 1129 1125 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Jern1">[11]</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 676 681 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1397 1402 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The human and mouse APOBEC3 (A3) protein family members, hA3F and G and mA3, respectively, are well-studied host factors that restrict retrovirus replication. [1]-[3]. These components of the innate cellular defense system inhibit retroviral propagation by inducing deamination of C-to-U residues in the negative strand of retroviral DNA during reverse transcription [4], resulting in a mutated provirus with biased G-to-A changes on the plus strand [5]-[8]. Due to the specificity of A3 for single-stranded DNA, the frequency of induced mutations forms an increasing gradient in the genome from the primer binding site (PBS) to the polypurine tract (PPT) [9]. In the case of HIV-1, whose genome contains a central PPT (cPPT), this effect results in dual gradients of G-to-A mutations from the PBS to the cPPT and the cPPT to the PPT [10]. A role of A3-mediated defense in more distant retroviral evolution became apparent when we recently showed that mA3 likely contributed to inactivation of the infectivity of some types of endogenous MLV at the time of their integration into the host germline around a million years ago [11]. Taken together, these observation show that A3 was active as an antiviral factor in the distant evolutionary past, and that it is so today. However, the effects these APOBEC3 restriction factors have had on the evolution of actively replicating retroviruses such as HIV-1 are less clear.
###end p 6
###begin p 7
###xml 245 248 245 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Bishop1">[5]</xref>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Chiu1">[12]</xref>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Rulli1">[13]</xref>
###xml 118 123 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The present study was undertaken to look for a signal of past A3-induced G-to-A changes in the sequence of modern day HIV-1 genomes. We hypothesized that the observed variation in G:A ratios in different viruses and in their sensitivities to A3 [5],[12],[13] is partly an effect of earlier A3-induced mutation and selection pressure on the virus genomes. Highly G-to-A mutated sequences are unlikely to be transmitted due to deleterious mutations. However, less efficient A3 activity, and thus fewer G-to-A mutations, could allow virus transmission, although with reduced efficiency. In this scenario, mutated A3 target sequences within which G-to-A mutations are the least deleterious are more likely to survive purifying selection pressure. This model predicts that as mutations accumulate with time, the ratio of nonsynonymous (NS) to synonymous (S) sites in probable A3 target sequences will increase with increasing virus generations more rapidly than at sites that are not A3 targets.
###end p 7
###begin p 8
###xml 91 100 91 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 339 342 339 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Yu1">[9]</xref>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene2">[14]</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 479 484 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 703 708 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 878 883 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To study the potential of human APOBEC3G (hA3G) to affect HIV-1 evolution, we developed an in silico model that takes into account the observed mutation gradient and the probabilities of hA3G-mediated mutation at each site, derived from the sequence contexts of mutation sites (hereafter referred to as "contexts") found in the literature [9],[14]. After adjustment for location in the provirus in our simulations, we found that the frequency of G-to-A mutations introduced into HIV-1 could be partly explained by the virus's genetic profile as well as its distribution of probable target sequence contexts. Our simulation approach is supported by independent experimental results obtained by passaging HIV-1 under conditions that permit a high level of A3G-induced mutation. Further analyses showed that the ratio of NS to S-mutations at hA3G target sites has increased during HIV-1 evolution compared to random controls, implying an evolution where A3 sites have had higher mutation rates than non-A3 sites and therefore been subjected to greater influence from purifying selection. We also analyzed the potential of low-level hA3G-mediated G-to-A mutations to give rise to naturally occurring drug resistance mutations.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human APOBEC3G mutation site contexts and probabilities
###end title 10
###begin p 11
###xml 207 210 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Yu1">[9]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene2">[14]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Jern1">[11]</xref>
###xml 413 422 413 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s001">Figure S1</xref>
###xml 660 669 660 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s001">Figure S1</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Jern1">[11]</xref>
###xml 1087 1096 1087 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s001">Figure S1</xref>
###xml 1098 1102 1098 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Henikoff1">[15]</xref>
###xml 1164 1165 1164 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1613 1617 1613 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Jern1">[11]</xref>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1240 1245 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To calculate the likelihood of hA3G-mediated G-to-A mutation at different sites in HIV-1, we analyzed mutation site contexts surrounding 1324 observed G-to-A mutations attributed to hA3G from the literature [9],[14]. Given the variability in these data and to minimize false predictions, we used our previous experience with mutation site context analyses [11] and included as many significant sites as possible (Figure S1). Thus, we collected sequences up to 3 bases 5' and 5 bases 3' of the G-to-A mutations. Using nucleotide frequencies at each offset position from the mutation target G-nucleotide, we constructed a position-specific scoring matrix (PSSM, Figure S1) using odds ratios (i.e., observed relative to expected nucleotide frequencies) and similar to the one derived for our previous study on endogenous nonecotropic MLVs [11]. Due to limited representation of observed non-A3G mediated G-to-A mutation sites in the literature, we included an artificial nucleotide frequency background to compensate for sampling artifacts using a previously described pseudo count method (Figure S1) [15]. Using automated PERL scripts we simulated a collection of 106 random mutation site contexts based on nucleotide frequencies observed in HIV-1. These data were used to derive a score distribution and a cumulative frequency distribution for probability calculation of context scores. Scores for the previously described G-to-A contexts were calculated and compared to the newly calculated score and cumulative frequency distributions. An analysis of G-to-A mutation site contexts collected from endogenous MLVs [11] supported this putative cutoff for likely A3 targets (data not shown). In addition to our simulations using all hA3G targets, we also included separate analyses using the 80% probability cutoff for introduction of G-to-A mutations (see below).
###end p 11
###begin title 12
Simulated retrovirus evolution from G-to-A mutations
###end title 12
###begin p 13
###xml 89 97 89 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g001">Figure 1</xref>
###xml 272 275 272 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Yu1">[9]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene1">[10]</xref>
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1131 1136 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mutations were simulated in HIV-1 (AF033819) using automated PERL scripts as outlined in Figure 1. Briefly, a mutation position was randomly selected using the previously observed dual gradients of increasing likelihood for mutation in the PBS-cPPT and cPPT-3'PPT regions [9],[10]. A score for the sequence context surrounding each randomly selected G-nucleotide was compared against cumulative frequency distributions of simulated random viral hA3G target contexts, and used to test whether a G-to-A mutation should be introduced at that site. If the context likelihood exceeded a random number between 0 and 1 a G-to-A mutation was introduced at that site. Failure to introduce a mutation initiated a new attempt at another random position. Information from successful mutations, including their location and whether they were synonymous (S) or nonsynonymous (NS) (i.e. unchanged and changed amino acid respectively) - was collected and followed by another round of simulated G-to-A mutation. Simulations were repeated until a stop codon was introduced into any gene or a normal ATG initiation codon was altered, after which the HIV-1 sequence with accumulated G-to-A mutations was collected into a database. In this way, we collected 4000 independent genomes with accumulated G-to-A mutations. All simulation rounds were performed using either contexts with probabilities over 80% or all G-nucleotides independent of context.
###end p 13
###begin title 14
Simulation strategies and analyses.
###end title 14
###begin p 15
###xml 266 275 266 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2A</xref>
A mutation position was randomly selected along the provirus, considering dual likelihood gradients, and analyzed for its surrounding context score and fitness to a hA3G target using simulated score and cumulative frequency distributions (as shown in the graph; see Figure 2A). A random number between 0 and 1 was chosen. If the context likelihood at the chosen site exceeded that value, a G-to-A mutation was introduced at that site. Failure to mutate initiated another attempt for a random mutation position. For a successful mutation, its position and synonymous or nonsynonymous change in amino acid were recorded and the mutated sequence was subjected to another round of mutation. This process was iterated until a stop codon was recorded in any ORF, at which point the sequence was collected into a database and a new simulation was initiated. Four thousand independent simulations were performed for each run.
###end p 15
###begin title 16
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Test of evolutionary G-to-A mutation footprints in HIV-1
###end title 16
###begin p 17
###xml 474 475 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 86 91 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 507 512 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To analyze the potential evolutionary footprints of hA3G-mediated G-to-A mutations in HIV-1 we used automated PERL scripts to test the ratios between the summarized probabilities of nonsynonymous to synonymous G-nucleotide contexts. To look for mutations that might have occurred during the evolutionary history of the virus, the same analysis was performed for putative ancestral G-nucleotide targets observed as A-nucleotides in the virus. Ratios were compared using a chi2 test (1 degree of freedom) for HIV-1 (AF033819) and HIVcon (group M consensus sequence derived from subgroup gene alignment consensus sequences) downloaded from .
###end p 17
###begin title 18
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Potential HIV-1 drug resistance from hA3G-mediated G-to-A mutations
###end title 18
###begin p 19
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Johnson1">[16]</xref>
###xml 370 379 370 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 247 250 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Locations of known HIV-1 protease inhibitor (PI), nucleoside RT inhibitors (NRTI), non-nucleoside RT inhibitor (NNRTI), integrase inhibitor (INI), and fusion inhibitor (FI) resistance mutation sites were collected from the literature [16] and the HIV drug resistance database (). We then analyzed all G-nucleotide contexts and used their calculated probabilities in our in silico model to estimate the potential likelihood for hA3G-mediated G-to-A mutations leading to drug resistance.
###end p 19
###begin title 20
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Experimental assessment of hA3G-induced mutations in HIV-1
###end title 20
###begin p 21
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Russell1">[17]</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Russell2">[18]</xref>
###xml 455 456 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 835 836 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 215 220 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 346 351 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1229 1233 <span type="species:ncbi:9913">calf</span>
Highly mutated HIV-1 samples were obtained from a passaging experiment. A detailed description of these studies [17] is available upon request. In brief, the YRHHY>A5 mutation at amino acids 40 to 44, which renders HIV-1 Vif unable to efficiently bind to hA3G but still be effective against hA3F [18], was inserted into the replication-competent HIV-1 plasmid pNL4-3 (AF324493) using overlapping PCR to generate pNL4-3-YRHHY>A5. For virus production, 4x106 293T cells were transfected with 20 microg of either pNL4-3 or pNL4-3-YRHHY>A5 and 1.2 microg pGL, which expresses the green fluorescent protein from a cytomegalovirus immediate early promoter (Invitrogen) to determine transfection efficiency. The virus-containing supernatant was harvested 48-hours after transfection, and assayed for RT activity. On day one of infection, 1x106 CEM cells were infected with 200 microl of virus supernatant (1000 RT units of virus) for five hours. The volume of medium was then increased to 5 ml. A 4 ml aliquot of cells and virus-containing supernatant was removed at two day intervals post infection (days 3, 5, 7 etc.), and stored at -70degreesC for subsequent analysis. A 4 ml aliquot of fresh CEM-CM (complete medium, RPMI+10% fetal calf serum+1% penicillin-streptomycin, in which the CEM cells were maintained). was then added to the remaining 2 ml cell and virus suspension and the sample incubated for another 2 days.
###end p 21
###begin p 22
###xml 160 181 152 173 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CAGGGAGATTCTAAAAG3&#8242;</named-content>
###xml 194 218 186 210 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GGATAAACAGCAGTTGTTGC3&#8242;</named-content>
###xml 566 591 558 583 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GAGATCCAGTTTGGAAAGGAC3&#8242;</named-content>
PCR reactions using 2 microl of extracted DNA from the infected cells, 1 microl High Fidelity Platinum Taq polymerase (Invitrogen) and 20 pmoles each of Vif F (5'CAGGGAGATTCTAAAAG3') and Vif R (5'GGATAAACAGCAGTTGTTGC3') primers were performed at 98 C for 2 minutes, followed by 30 cycles at 98 C for 30 seconds, 55 C for 30 seconds and 72 C for one minute. Final PCR product extension was performed at 72 C for 10 minutes. The PCR product was then cloned into the TOPO TA vector (Invitrogen) and the individual clones were sequenced using the primer NL43 seq 4921F (5'GAGATCCAGTTTGGAAAGGAC3').
###end p 22
###begin title 23
###xml 18 27 18 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
Evaluation of the in silico model
###end title 23
###begin p 24
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Jern1">[11]</xref>
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Russell2">[18]</xref>
###xml 394 403 394 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 460 468 460 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 481 484 481 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 704 712 704 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Mutation site contexts from the in vitro experiments described above were collected using automated PERL scripts as described earlier [11]. Scores and likelihoods were calculated in our current model. In these experiments, G-to-A mutations were considered either natural RT errors or hA3G-mediated changes since the YRHHY>A5 vif mutant is still capable of inhibiting hA3F [18]. To evaluate our in silico model, we simulated the number of mutations we observed in vitro on the same vif region of pNL4-3 (AF324493; positions 5041-5770). We then isolated all contexts surrounding simulated G-to-A mutations using our automated PERL scripts and calculated scores and likelihoods for direct comparison to the in vitro results.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Simulated HIV-1 evolution due to G-to-A mutations
###end title 26
###begin p 27
###xml 78 81 78 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Yu1">[9]</xref>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene2">[14]</xref>
###xml 294 303 294 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s001">Figure S1</xref>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 366 375 366 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2A</xref>
###xml 497 506 497 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2A</xref>
###xml 774 778 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene2">[14]</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene2">[14]</xref>
###xml 982 991 982 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2A</xref>
###xml 1283 1287 1283 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Jern1">[11]</xref>
###xml 219 224 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 399 404 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Using automated PERL scripts and previously identified hA3G-induced mutations [9],[14], we extracted sequence contexts extending 3 bases upstream and 5 bases downstream of each potential G-to-A mutation position in the HIV-1 genome and constructed a Log position-specific scoring matrix (PSSM, Figure S1). We next created a random set of 106 mutation site contexts (Figure 2A, circles) based on the HIV-1 base composition and plotted the histogram and cumulative frequencies of that distribution (Figure 2A, diamonds). This analysis yielded an approximately normal distribution with a mean score of -0.7 and a standard deviation of 1.5 (black boxplot). To determine the pattern of actual mutations, we then tested context scores of previously observed G-to-A mutation sites [14] against this distribution. The distribution of calculated probabilities of these mutation "hotspots" [14] was significantly skewed relative to random, with a mean of 2.3 and a standard deviation of 1.1 (Figure 2A; red boxplot), with 96% of mutations at sites with a score of 80% or greater, suggesting that a score threshold of 80% would capture the large majority of actual hA3G-mutation targets. We also found support for an 80% cutoff when G-to-A mutation site contexts collected from endogenous MLVs [11] were analyzed in the same way using simulated score distributions.
###end p 27
###begin title 28
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human APOBEC3G target context probabilities and simulation results in HIV-1.
###end title 28
###begin p 29
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 573 576 573 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Yu1">[9]</xref>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene2">[14]</xref>
###xml 790 798 790 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g001">Figure 1</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene1">[10]</xref>
###xml 112 117 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 567 572 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 837 842 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) The distribution of scores for 106 random sequence contexts derived from observed nucleotide frequencies in HIV-1 extending 3 bases upstream and 5 bases downstream of the target base is shown by the black circles. The black diamonds show the cumulative frequency distribution, and a boxplot representing this distribution (median, flanked by boxes indicating first and third quartiles and whiskers for high and low values) is also shown in black. The distribution of corresponding context scores for previously observed sites of hA3G-mediated G-to-A mutations in HIV-1 [9],[14] is shown by the red boxplot. (B, C) Frequency of accumulated nonsynonymous (B) and synonymous mutations (C) at contexts with >80% probability derived from 4000 independent simulations of virus evolution (see Figure 1) are shown (in black) relative to the HIV-1 provirus. The simulated mutations show the expected dual mutation gradients [10], PBS-cPPT, and cPPT-3'PPT. The differences in slope between 5'- and 3'-gradients reflect the different gradient lengths along the virus sequence. Grey symbols show the distribution of all potential G-to-A mutation sites as a function of their relative probabilities derived from PSSM scores, thus verifying that the distributions observed are not due to a nonuniform distribution of high probability hA3G targets.
###end p 29
###begin p 30
###xml 99 108 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 116 124 116 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g001">Figure 1</xref>
###xml 316 331 316 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2B and C</xref>
###xml 592 601 592 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2B</xref>
###xml 622 631 622 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2C</xref>
###xml 1129 1144 1129 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2B and C</xref>
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 550 555 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1246 1251 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To estimate the potential of hA3G-mediated mutations to contribute to HIV-1 evolution, we used our in silico model (Figure 1) to simulate stochastic accumulation of G-to-A mutations in the genome before an obviously lethal mutation (introduction of a stop codon or loss of an initiation codon) appeared in any gene (Figure 2B and C). The simulation took into account both the dual hA3G mutation gradients (PBS-cPPT and cPPT-3'PPT) and the target probability at each G-nucleotide calculated from the surrounding sequence context. A collection of 4000 HIV-1 sequences - with nonsynonymous (NS, Figure 2B) and synonymous (S, Figure 2C) mutations accumulated until one lethal mutation was introduced - was analyzed. Most of the simulated mutations displayed the expected dual gradient (black circles). Very infrequent mutations at the bottom of the graphs result from contexts that are at or very close to the probability cutoff. To ensure that this pattern did not reflect a nonuniform distribution of high probability hA3G targets, we also plotted the distribution of context probability scores for all G-residues. As can be seen (Figure 2B and C, gray squares), there is no indication of an uneven distribution of context probabilities across the HIV-1 provirus.
###end p 30
###begin p 31
###xml 121 129 121 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g003">Figure 3</xref>
###xml 315 323 315 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2</xref>
###xml 817 825 817 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g003">Figure 3</xref>
###xml 1105 1114 1105 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s002">Figure S2</xref>
###xml 1538 1547 1538 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
The distribution of the number of accumulated G-to-A changes per provirus resulting from our simulations is presented in Figure 3. For comparison, simulations were also repeated in which all G-nucleotide sites were considered for successful mutations and compared to those derived using the 80% probability cutoff (Figure 2 and above). As expected from our model, without selection pressure on the virus sequence, NS (red) to S (blue) mutation ratios were consistent (approximately 3:1) independent of the number of mutations that were introduced into the viruses. Further, the numbers of random G-to-A mutations introduced before a stop codon appeared averaged about 1.6 S and 4.0 NS mutations, but some individual genomes accumulated as many as 40 substitutions when an 80% hA3G target probability cutoff was used (Figure 3). This value increased to 72 when all G-nucleotides were considered. Thus, when all sites were used in simulations, mutations were more widespread and high scoring hA3G target contexts accumulated slightly fewer mutations than in simulations where a probability cutoff was used (Figure S2). This pattern reflects the fact that higher scoring sites have a larger proportion of potential stop codons resulting from G-to-A mutations. Together, these simulation results suggest that a moderate level of G-to-A mutations is tolerable in the virus sequence during its evolution without causing significant harm (i.e. premature stops), although the significance of other NS mutations was not assessed in our simplified in silico model.
###end p 31
###begin title 32
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Simulation of hA3G-mediated HIV-1 evolution.
###end title 32
###begin p 33
###xml 16 25 16 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A total of 4000 in silico G-to-A mutated HIV-1 sequences is indicated by grey crosses plotted as the number of genomes vs. number of mutations per genome. Bars show nonsynonymous (red) and synonymous (blue) mutations. Boxplots below show the distributions of viruses with hA3G-induced mutations, with the median value flanked by boxes indicating the quartiles and whiskers indicating the highest and lowest number of mutations in the distributions. Solid boxplots show distributions from simulations using 80% probability cutoffs for mutations and dashed boxplots show equivalent results considering all context probabilities. Complementing boxplots on the right show distributions of accumulated mutations from the simulations using hA3G.
###end p 33
###begin title 34
G-to-A mutation footprints in retrovirus evolution
###end title 34
###begin p 35
###xml 69 78 69 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 177 182 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Given the number of G-to-A mutations that could be introduced in our in silico model, it is conceivable that a low-level of hA3G-mediated mutations has been introduced into the HIV-1 sequence during its recent history and that these mutations might still be distinguishable from the more random RT-induced G-to-A mutations.
###end p 35
###begin p 36
###xml 45 54 45 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 62 71 62 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2A</xref>
###xml 169 178 169 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g004">Figure 4A</xref>
###xml 364 373 364 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g004">Figure 4A</xref>
###xml 1144 1153 1144 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g004">Figure 4A</xref>
###xml 1347 1348 1345 1346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1420 1429 1418 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g004">Figure 4B</xref>
###xml 2306 2315 2304 2313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g004">Figure 4B</xref>
###xml 1206 1211 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1748 1753 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2007 2012 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2401 2406 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To investigate this possibility, we used our in silico model (Figure 2A) to calculate the likelihood of each G-nucleotide context fit to be a hA3G target as outlined in Figure 4A. Briefly, we summarized the likelihood scores for each G-nucleotide context and tested for mutation type when changed into an A-nucleotide. We then calculated a ratio of NS to S sites (Figure 4A). In the same way, we summarized likelihood scores for currently residing A-nucleotides, which we treated as putative ancestral G-nucleotides. Evolutionary theory predicts that the least costly mutations will have a higher chance to become fixed in the viral sequence and that deleterious mutations, i.e. mostly NS, will naturally be sorted out from the virus population due to purifying selection pressure. Conversely, among target sequences in which the target G-nucleotide has been changed to an A (referred to here as "putative" targets), the NS/S ratio should increase with time. Thus, the action of A3 on ancestral virus should have left a footprint on the viral genome in the form of an increased NS/S ratio at A3G targets relative to putative ancestral targets (Figure 4A). In search of such a footprint, we tested a modern HIV-1, subtype B sequence for the score and likelihood ratios at potential hA3G target sites and found an increased NS/S ratio (p = 0.07, chi2 test) when compared to the cognate ratios at putative ancestral sites (Figure 4B). Indeed, analyses using the group M consensus sequence reconstructed from subgroup gene consensus sequences (HIVcon), which most likely has eliminated some background variation, supported our finding with a higher level of significance (p = 0.04). Increasing the target score cutoff led to slightly higher ratios for HIV-1, whereas a decreased cutoff had the opposite effect on both sequences (data not shown). To ensure that differences in NS/S ratios between currently observed G-nucleotides and putative ancestral hA3G mutation site contexts were not artifacts from random HIV-1 RT errors, we repeated our analyses by random sampling of codons from the virus sequences while not considering context scores or likelihoods. In these controls we found no significant differences in nonsynonymous to synonymous ratios between the current and putative ancestral G-nucleotides (Figure 4B). Thus, we propose that hA3G-induced mutation has had a significant influence on the HIV-1 genome in its evolutionary past.
###end p 36
###begin title 37
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
G-to-A mutation footprints formed during the HIV-1 evolutionary past.
###end title 37
###begin p 38
###xml 897 898 895 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 432 437 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) The principle of this analysis. Briefly, scores were summarized for contexts surrounding G-nucleotides and A-nucleotides (treated as putative ancestral G) and analyzed for nonsynonymous (NS) or synonymous (S) change if mutated G-to-A. For comparison, NS/S ratios were also calculated for random codons derived from nucleotide frequencies at codon positions found in the provirus ORFs. (B) The NS/S ratio differences in a modern HIV-1 subtype B sequence (AF033819) are shown in the left panel and HIVcon (group M consensus sequence derived from the individual subgroup consensus sequences) are in the right panel. The NS/S ratio of hA3G targets (blue) are compared to corresponding putative ancestral targets (red) with an A-nucleotide at the target site as well as to expected ratios derived from G- and A-nucleotide frequencies and positions in randomly selected codons. P-values from the chi2 distribution (1 degree of freedom) are shown above the bars.
###end p 38
###begin title 39
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Potential HIV-1 drug resistance from hA3G-mediated G-to-A mutations
###end title 39
###begin p 40
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Harris3">[19]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Nathans1">[21]</xref>
###xml 704 707 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 709 712 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pro</italic>
###xml 714 717 714 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 722 725 722 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 727 736 727 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s002">Figure S2</xref>
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 692 697 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 776 781 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 892 897 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our analysis implies that, over its evolutionary history, HIV-1 has been subjected to sublethal G-to-A mutations, which have not had sufficient effect to stop virus proliferation and transmission. An imperfectly functioning Vif protein might explain this result. Vif has become an interesting target for new anti-viral drugs [19]-[21] since inhibition of its activity could increase the chance for hA3G to more efficiently restrict virus spread. However, suboptimal blocking of Vif might also lead to an increase in sublethal hA3G-induced G-to-A mutations, and potentially more rapid appearance of drug resistance. To test this possibility, we analyzed the G-nucleotide contexts in the major HIV-1 genes gag, pro, pol and env (Figure S2). We hypothesized that combinations of HIV-1 inhibitory drugs, including a potential Vif-targeting drug, could lead to an increased selection pressure for HIV-1, which might then benefit from low-level hA3G-mediated G-to-A mutations, allowing it to escape other drugs like protease-, RT-, integrase- and fusion-inhibitors.
###end p 40
###begin p 41
###xml 91 100 91 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 193 201 193 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g003">Figure 3</xref>
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g005">Figure 5</xref>
###xml 305 314 305 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s002">Figure S2</xref>
###xml 922 931 922 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s002">Figure S2</xref>
###xml 688 693 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To test this possibility, we screened a total of about 52,000 mutations resulting from our in silico simulations using either 80% probability cutoffs or all G-nucleotide context probabilities (Figure 3), our analyses showed a total of 695 mutations introduced at known drug resistance sites (Figure 5 and Figure S2). However, in no case was the frequency of mutations at sites with high probability scores greatly different from the probability for all G-to-A mutations regardless of score. Thus, it seems unlikely that increased drug resistance would arise as a significant side effect of an increased, but still low-level, hA3G-induced mutation rate resulting from using Vif as an anti HIV-1 drug target. However, caution is indicated where, due to an altered selection pressure from anti-viral regimens used in combination, multiple G-to-A mutations in adjoining contexts could potentially lead to new drug resistance (Figure S2).
###end p 41
###begin title 42
Drug resistance mutations potentially caused by G-to-A mutations.
###end title 42
###begin p 43
###xml 95 98 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 123 132 123 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s002">Figure S2</xref>
###xml 236 245 236 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2A</xref>
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Codons for known mutation sites are concatenated from full mutation site contexts in the HIV-1 gag, pol and env sequences (Figure S2). Lower panel: black bars indicate calculated probabilities at G-to-A mutation positions (derived from Figure 2A). The upper panel shows stacked bars for accumulated mutations at each position from simulations using the 80% probability cutoff (nonsynonymous red or synonymous blue) or all probabilities (orange or light blue). Abbreviations: PI, protease inhibitors; NRTI, nucleoside RT inhibitors; NNRTI, non-nucleoside RT inhibitors; INI, integrase inhibitors; FI, fusion inhibitors.
###end p 43
###begin title 44
Experimental evaluation of the model
###end title 44
###begin p 45
###xml 12 21 12 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 79 82 79 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Yu1">[9]</xref>
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene1">[10]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene2">[14]</xref>
###xml 147 155 147 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Russell2">[18]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Russell1">[17]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Russell2">[18]</xref>
###xml 719 722 719 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 1163 1166 1163 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 1451 1455 1451 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Russell1">[17]</xref>
###xml 1456 1460 1456 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Russell2">[18]</xref>
###xml 220 225 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our current in silico model is based on previously published experimental data [9],[10],[14]. To test the role of hA3G more directly, we performed in vitro passaging experiments on CEM cells using a previously described HIV-1 vif mutant [18] that was previously shown to have lost the ability to inhibit hA3G, but could still inhibit hA3F; therefore G-to-A mutations were considered to result from either RT-induced errors or hA3G-mediated changes [17],[18]. Western blotting analysis indicated that the T cell line used did not express detectable levels of hA3F (data not shown), further supporting the view that hA3F did not significantly contribute to the pool of G-to-A mutations analyzed. We also analyzed another vif mutant which is unable to block the activity of hA3F but can block the activity of hA3G (DRMR>A4). This mutant replicated with kinetics that were indistinguishable from those of the wild type virus (unpublished observations). Thus, we are confident that these cells express little or no hA3F. To assess the distribution of accumulated mutations, we passaged the virus sequentially for three rounds over three months, and then sequenced the vif region (corresponding to positions 5041-5770 of pNL4-3), amounting to about 166,000 nucleotides from 227 separate genomes. We identified a total of 585 G-to-A mutations and calculated scores and probabilities for their respective hA3G mutation site contexts. In the raw sequence data [17],[18], we noted that approximately 87% of the mutations were in GG dinucleotide contexts, agreeing with frequencies observed by us and others for vif-defective viruses produced from cells that exclusively express hA3G (transfected 293T cells).
###end p 45
###begin p 46
###xml 16 25 16 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 95 103 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 259 268 259 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g006">Figure 6A</xref>
###xml 330 339 330 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g006">Figure 6B</xref>
###xml 422 423 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 465 474 463 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 509 517 507 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 561 569 559 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 630 639 628 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 1062 1065 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To evaluate our in silico model predictions we simulated the same number of mutations observed in vitro into the same pNL4-3 sequence. A comparison of the observed and predicted frequencies of G-to-A mutations as a function of context probability is shown in Figure 6A, and the corresponding cumulative distributions are shown in Figure 6B. We could not detect any significant differences in the mean values (P = 0.41, chi2 test, 30 degrees of freedom) between our in silico predictions and observations from in vitro experiments. The larger variation observed in vitro (red confidence intervals and red outliers) compared to the in silico results (blue confidence intervals) indicates that other factors such as nucleic acid structure might also influence the efficiency of hA3G-mediated mutation. However, given the similarity of the cumulative distribution, this contribution is likely to be small compared to the primary sequence likelihood used in our predictions, implying that our model is capable of accurately capturing hA3G-mediated mutagenesis during HIV replication.
###end p 46
###begin title 47
###xml 18 27 18 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Validation of the in silico model for hA3G-mediated G-to-A mutations in HIV-1.
###end title 47
###begin p 48
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 345 354 345 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 366 374 366 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g001">Figure 1</xref>
###xml 379 387 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g002">Figure 2</xref>
###xml 517 526 517 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 538 546 538 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) The number of mutations in HIV-1 (pNL4-3 vif-region) from in vitro experiments plotted against their respective calculated probability scores in red symbols. The trend is presented as a solid red line flanked by dashed lines indicating the 95% confidence interval. An equal number of mutations was simulated over the same sequence using our in silico model (see Figure 1 and Figure 2) is shown by the blue symbols, blue trend line and 95% confidence interval. (B) The cumulative distributions of contexts mutated in silico (blue) and in vitro (red) plotted against their calculated probabilities.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 281 290 281 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 590 593 590 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Harris1">[2]</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Chiu1">[12]</xref>
###xml 599 603 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Holmes1">[22]</xref>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Jern2">[23]</xref>
###xml 680 684 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-OhAinle1">[24]</xref>
###xml 1026 1030 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Jern1">[11]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 365 370 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 510 515 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 556 561 <span type="species:ncbi:9606">human</span>
###xml 644 649 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 736 741 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1100 1105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human A3F and A3G are potent antiviral factors whose activities, if not blocked by Vif, are capable of causing high levels of G-to-A mutations in newly made viral DNA. However, their role in the genesis of naturally occurring mutations is unclear. In this report, we have built an in silico model to simulate G-to-A mutations and to analyze their potential role in HIV-1 evolution and drug resistance. We have found that hA3G activity acting on prior generations of virus has left detectable footprints in the HIV-1 genome. Although there are at least ten human APOBEC members (reviewed in [2],[12],[22]), including at least one more potential HIV-1 restriction factor, hA3H [23],[24]; we have chosen to focus on the effects of hA3G on HIV-1 to limit our predictions and simplify our model in order to reach realistic conclusions. We also elected to include a wider mutation site context than the more commonly used GG-dinucleotide, consistent with our previous studies of nonrandom mA3 targets in endogenous nonecotropic MLV [11], to distinguish hA3G-induced G-to-A changes from randomly introduced HIV-1 RT errors.
###end p 50
###begin p 51
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Mangeat1">[7]</xref>
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Zhang1">[8]</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Berkhout1">[25]</xref>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Muller1">[26]</xref>
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 283 288 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 364 369 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 571 576 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 633 638 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
G-to-A hypermutation in HIV-1 is clearly capable of limiting virus proliferation due to the introduction of both missense and nonsense mutations, which can be directly lethal to the virus [7],[8]. The origin of G-to-A changes and their contribution to the bias and A-richness of the HIV-1 genome have been studied, as has the role of hA3G as a potential driver of HIV-1 evolution, although mutations introduced by RT are likely to be of greater general importance in the evolution of drug-resistant variants [25]. The hypothesis that hA3G has played an important role in HIV-1 evolution was also discussed in another recent study of HIV-1 nucleotide and codon usage bias [26].
###end p 51
###begin p 52
###xml 658 667 658 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif(-)</italic>
###xml 1163 1171 1163 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1196 1205 1196 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 1256 1264 1256 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1804 1808 1804 1808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Keele1">[27]</xref>
###xml 94 99 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 125 130 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 743 748 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1537 1542 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1756 1761 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To address the potential role of hA3G-mediated G-to-A mutations, as distinguished from random HIV-1 RT-introduced errors, in HIV-1 evolution, we analyzed individual mutation sites in hA3G target contexts, calculated from independent experimental data. To minimize bias due to purifying selection, the impaired vif gene was chosen for analysis of G-to-A mutation frequency. Another practical reason was that we needed to verify with each sequence that the Vif inactivating mutation was not reverted to regain Vif function. Thus, analyzing sequences from the Vif/Vpr region allowed us to verify the Vif-deficient phenotype. When the results obtained from this in silico analysis were compared with the accumulation of G-to-A mutations in vif(-) HIV-1, passaged repeatedly in CEM cells, we saw no significant difference in mean number of mutations as a function of their context score, although the variance of this value was much greater in the latter analysis, perhaps reflecting effects of secondary structure or some other feature on the A3G mediated mutation frequency. It should be emphasized that, although we used the same total number of mutations observed in vitro for our simulation, the in silico model was otherwise completely independent of the in vitro study, yet the two did not give significantly different results. Thus, the similarity between experiment and simulation supports the accuracy of our model, as well as its suitability for estimating mutational events. Further support for our hA3G footprint observations in HIV-1 and our estimates of moderately high tolerance of G-to-A changes before introduction of deleterious stop mutations in our simulations could also be observed in a recent study of genetic variation in early founder HIV-1 virus populations from primary infections [27].
###end p 52
###begin p 53
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Jern1">[11]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Armitage1">[28]</xref>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Lee1">[29]</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Berkhout1">[25]</xref>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Muller1">[26]</xref>
###xml 102 107 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 496 501 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our results imply that although hA3G-mediated G-to-A mutations likely have had a detectable effect on HIV-1 evolution that is traceable through mutational footprints Indeed, several studies of endogenous retroviruses from different genera and host species have recently shown evolutionary effects caused by A3-introduced G-to-A mutations, some of which likely contributed to provirus inactivation [11],[28],[29]. However, it is likely that other mutagens, including other A3 proteins, as well as HIV-1 RT are also important contributors to the nucleotide bias in the virus genome [25],[26].
###end p 53
###begin p 54
###xml 183 186 183 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Harris1">[2]</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Harris3">[19]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Nathans1">[21]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Pillai1">[30]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Kearney1">[31]</xref>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Palmer1">[32]</xref>
###xml 886 890 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Pillai1">[30]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Hache1">[33]</xref>
###xml 901 910 901 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 1255 1258 1255 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Yu1">[9]</xref>
###xml 1259 1263 1259 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Suspene1">[10]</xref>
###xml 1705 1709 1705 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000367-Mulder1">[34]</xref>
###xml 1846 1855 1846 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000367.s002">Figure S2</xref>
###xml 2234 2242 2234 2242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000367-g005">Figure 5</xref>
###xml 2511 2520 2511 2520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 366 371 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 496 501 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 533 538 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 677 682 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1127 1132 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1657 1662 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2067 2072 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 Vif protein has drawn interest as a drug target since interfering with its action could theoretically allow hA3G to escape degradation and thus restrict virus proliferation [2],[19],[21]. However, an increased rate of G-to-A mutations compared to that from the error prone RT enzyme, as a result of an incomplete block of Vif, could potentially be used by HIV-1 to accelerate evolution of drug resistance and immune escape [30]. Variation at G-nucleotide sites is not uncommon within a HIV-1 population and polymorphism at HIV-1 drug resistance sites has been observed in single genome sequencing studies [31],[32]. Here, we used our model to estimate the chance for HIV-1 to benefit from such increased genetic variation due to hA3G-introduced mutations. G-to-A-induced drug resistance has been described, but until now its discussion has focused on GG-dinucleotide contexts [30],[33]. Our in silico model instead uses the extended information of the sequence context surrounding the mutation site and enabled us to calculate a probability score for each possible site. This approach enabled us to screen the entire HIV-1 genome and estimate the likelihood of mutations in the context of the dual gradients arising during reverse transcription [9],[10]. The moderate number of hA3G-mediated G-to-A mutations at known drug resistance sites implies that the hA3G-Vif interaction can be a potential target for new antiviral drugs, with little or no concern for enhancement or appearance of resistance to other antiviral drugs. The increased rate of G-to-A mutations from hA3G does not seem overly problematic for the evolution of drug resistance in HIV-1. However, as pointed out by Mulder et al, [34] it cannot be entirely excluded that other A3-induced changes in high scoring hA3G target sites in the vicinity of current drug targets (Figure S2) not associated with drug resistance to date, might give rise to compensatory or even new resistance mutations. In that study, the authors describe a mutation, M184I in RT, which emerged in a partially impaired HIV-1 vif mutant. The conclusion that hA3G was causing this mutation was based on the dinucleotide context and the results are somewhat contradictory to our findings (Figure 5). Given that G-to-A mutations are the most common RT errors and our previous experience and support from larger mutation site contexts derived from the literature, we emphasize that such a short dinucleotide context is unlikely to be sufficient to readily distinguish bona fide hA3G induced G-to-A mutations from RT error.
###end p 54
###begin p 55
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 544 549 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In conclusion, we have found evidence that low levels of APOBEC3G-induced mutagenesis have affected HIV-1 evolution, leading to enhanced rates of variation at sites with a high probability of match to the optimum context for hA3G-mediated deamination. The low levels of G-to-A mutation could allow the viruses to achieve enhanced genetic variation. However, since the predicted effect on resistance to standard antiviral drugs is likely to be small, we propose that concerns over increased resistance mutations should not impede development of HIV-1 Vif as a candidate drug target.
###end p 55
###begin title 56
Supporting Information
###end title 56
###begin p 57
Position-specific scoring matrix (PSSM) derived from observed G-to-A mutation site contexts found in the literature.
###end p 57
###begin p 58
(0.06 MB PDF)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin p 60
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 (AF033819) gag, pol and env polyprotein ORFs and amino acid translations. Lower panel black bars indicate calculated hA3G context probabilities for each. Upper panels show stacked bars for accumulated number of simulated mutations. Red bars indicate nonsynonymous (i.e. change in amino acid) mutations and blue bars indicate synonymous mutations. Dark shaded bars (red and blue) represent simulations using an 80% probability cutoff for mutations and lighter shaded bars (orange and light blue) represent simulations using all context probabilities. Known resistance mutations are shown as shaded codons and amino acids. Grey shading represents amino acid changes due to mutations other than G-to-A editing which are shaded in red.
###end p 60
###begin p 61
(0.30 MB PDF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
###end article-title 64
###begin article-title 65
Retroviral restriction by APOBEC proteins.
###end article-title 65
###begin article-title 66
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
APOBEC3 inhibits mouse mammary tumour virus replication in vivo.
###end article-title 66
###begin article-title 67
Reverse Transcriptase and the Generation of Retroviral DNA.
###end article-title 67
###begin article-title 68
Cytidine deamination of retroviral DNA by diverse APOBEC proteins.
###end article-title 68
###begin article-title 69
DNA deamination mediates innate immunity to retroviral infection.
###end article-title 69
###begin article-title 70
###xml 32 37 <span type="species:ncbi:9606">human</span>
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
###end article-title 70
###begin article-title 71
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.
###end article-title 71
###begin article-title 72
###xml 83 86 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.
###end article-title 72
###begin article-title 73
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication.
###end article-title 73
###begin article-title 74
###xml 54 77 <span type="species:ncbi:11786">murine leukemia viruses</span>
Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses.
###end article-title 74
###begin article-title 75
The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements.
###end article-title 75
###begin article-title 76
###xml 16 22 <span type="species:ncbi:10090">Murine</span>
###xml 35 40 <span type="species:ncbi:9606">Human</span>
###xml 55 61 <span type="species:ncbi:10090">Murine</span>
Interactions of Murine Apobec3 and Human Apobec3g with Murine Leukemia Viruses.
###end article-title 76
###begin article-title 77
###xml 84 87 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
###end article-title 77
###begin article-title 78
Using substitution probabilities to improve position-specific scoring matrices.
###end article-title 78
###begin article-title 79
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Update of the drug resistance mutations in HIV-1: 2007.
###end article-title 79
###begin article-title 80
###xml 88 93 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA.
###end article-title 80
###begin article-title 81
###xml 31 66 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
###end article-title 81
###begin article-title 82
###xml 22 25 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Enhancing immunity to HIV through APOBEC.
###end article-title 82
###begin article-title 83
###xml 46 81 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.
###end article-title 83
###begin article-title 84
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Small-molecule inhibition of HIV-1 Vif.
###end article-title 84
###begin article-title 85
APOBEC-mediated viral restriction: not simply editing?
###end article-title 85
###begin article-title 86
Host-retrovirus arms race: trimming the budget.
###end article-title 86
###begin article-title 87
###xml 63 68 <span type="species:ncbi:9606">human</span>
Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.
###end article-title 87
###begin article-title 88
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations.
###end article-title 88
###begin article-title 89
Guanine-adenine bias: a general property of retroid viruses that is unrelated to host-induced hypermutation.
###end article-title 89
###begin article-title 90
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.
###end article-title 90
###begin article-title 91
###xml 49 84 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 89 123 <span type="species:ncbi:45617">human endogenous retrovirus HERV-K</span>
Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.
###end article-title 91
###begin article-title 92
###xml 28 33 <span type="species:ncbi:9606">human</span>
Hypermutation of an ancient human retrovirus by APOBEC3G.
###end article-title 92
###begin article-title 93
###xml 102 107 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3).
###end article-title 93
###begin article-title 94
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase.
###end article-title 94
###begin article-title 95
###xml 17 52 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.
###end article-title 95
###begin article-title 96
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 52 55 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance.
###end article-title 96
###begin article-title 97
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cytidine deamination induced HIV-1 drug resistance.
###end article-title 97
###begin p 98
The authors have declared that no competing interests exist.
###end p 98
###begin p 99
This work was supported by grant R37 CA 089441 from the National Cancer Institute to JMC. PJ was supported by a fellowship from the Wenner-Gren foundation (Sweden). This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. JMC was a Research Professor of the American Cancer Society, with support from the George Kirby Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 99

